|Articles|November 6, 2015
Elevating the Patient Voice: Leveraging Patients' Expertise to Advance Drug Development
Author(s)DIA
Advertisement
A report on progress with PDUFA V commitments to hold patient-focused drug development meetings; and on how patient focus is being built into 21st Century Cures legislation and forthcoming PDUFA VI reauthorization.
This article appeared in the August 2015 issue of
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5